Former Idera Pharmaceuticals, Inc. CEO at Helm of AesRx, New Startup With Sickle Cell Drug

Bookmark and Share

Xconomy.com -- Stephen Seiler has been hunting for cash to advance an experimental therapy for sickle cell disease into initial human studies. And the veteran biotech executive, the former CEO of Cambridge, MA-based Idera Pharmaceuticals (NASDAQ:IDRA), has founded a startup in Newton, MA called AesRx to carry out his goal.

Back to news